Progesterone Receptors

Cymipristone is a potent progesterone receptor antagonist. It exhibits significant biological activity by inhibiting the effects of progesterone, which is crucial for maintaining pregnancy. This compound is primarily investigated for its potential application in the termination of intrauterine pregnancy and may have implications for reproductive health research.

Tosagestin is a 19-nortestosterone-derived progestagen that primarily targets progestin receptors. It effectively suppresses ovarian function to inhibit ovulation and exhibits the ability to inhibit cell growth in T47D-S breast cancer cells. This compound is valuable for research applications involving reproductive biology and cancer studies.

Norgestomet is a synthetic progesterone receptor agonist that exhibits high purity and strong binding affinity for the progesterone receptor. It is utilized in various research applications, including studies on reproductive biology and hormone regulation. The compound's efficacy makes it a valuable tool for exploring the biological mechanisms mediated by progesterone signaling.

Anordrin is a contraceptive agent that primarily exerts its effects through estrogenic activity. It has been shown to induce a decrease in serum progesterone levels in rat models, as well as inhibit endometrial epithelial cell mitosis. Additionally, Anordrin demonstrates the ability to counteract non-alcoholic fatty liver disease (NAFLD) induced by Tamoxifen in mouse models, highlighting its dual role as both an anti-estrogenic and estrogenic agent. This compound is valuable for research applications focused on reproductive health and endocrine regulation.

ZK112993 is a potent antagonist of the progesterone receptor (PR). This compound has been shown to significantly inhibit the growth of T61 human tumors in nude mice, making it valuable for research in cancer biology and therapeutic applications targeting hormone-responsive tumors. The utility of ZK112993 extends to studies focused on progesterone signaling pathways and their implications in oncogenesis.

Algestone acetophenide is a synthetic progesterone that functions primarily as a progestin. It is utilized in combination with estrogen to formulate long-acting injectable contraceptives, demonstrating efficacy in regulating menstrual cycles and preventing ovulation. Its applications extend to reproductive health research, offering insights into hormonal regulation and contraceptive technologies.

Dexamethasone oxetanone is an antagonist of glucocorticoid receptors, specifically acting as a potent agonist for progesterone receptor isoforms A and B. This compound exhibits significant antiprogestin activity, making it valuable in studies exploring progesterone signaling pathways. Dexamethasone oxetanone is relevant for research applications in reproductive biology and endocrinology, particularly in understanding the modulation of hormone receptors and their biological effects.

Brofoxine is a progesterone receptor modulator that exhibits anti-anxiety properties. It selectively targets the progesterone receptors to modulate their activity, contributing to its potential therapeutic effects. Brofoxine is primarily utilized in research focused on anxiety disorders and the roles of hormone regulation in mental health.

Melengesterol is a steroidal progestin belonging to the 17α-hydroxyprogesterone class, functioning primarily as an antineoplastic agent. This compound exhibits significant anti-cancer properties and is utilized in research exploring its effects on various hormone-dependent tumors. Its ability to modulate progesterone receptors makes it a valuable tool for studying steroid hormone signaling pathways in cancer biology.

CP8754 is a selective antagonist of the human progesterone receptor (hPR), acting primarily by competitively inhibiting the binding of [3H]-progesterone. This compound effectively impedes progesterone-mediated signaling, as evidenced by its ability to inhibit both exogenous luciferase and endogenous alkaline phosphatase expression in vitro, and to suppress rabbit endometrial transformation in vivo. CP8754 exhibits minimal binding affinity for human glucocorticoid receptors, estrogen receptors, and rat androgen receptors, making it a valuable tool for investigating progesterone-related diseases, including breast cancer, endometriosis, uterine fibroids, and hormone-dependent tumors.

PF 02367982 is a selective progesterone receptor (PR) antagonist, exhibiting a potency with an IC50 value of 47.3 nM. This compound demonstrates oral bioactivity, making it suitable for in vivo research applications. PF 02367982 is primarily utilized in studies investigating the role of PR modulation in various biological systems and potential therapeutic interventions in hormone-related conditions.

Telapristone is a potent progesterone antagonist that specifically targets the progesterone receptor. This compound is instrumental in researching gynecological conditions such as uterine fibroids and endometriosis. Its ability to modulate progesterone signaling makes it a valuable tool for investigating the role of hormonal pathways in these disorders.

Norgestrienone is a progestin receptor agonist that mimics the effects of progesterone. It is primarily utilized in hormonal contraceptives, often in combination with ethinylestradiol, to regulate reproductive functions. Additionally, Norgestrienone features alkyne groups, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition reactions, making it a versatile tool for chemical biology studies. Its applications extend to research on hereditary angioneurotic edema, providing insights into this condition's underlying mechanisms.

17α-Ethynyl-19-nor-Δ-5(6)-androsten-17β-ol-3-one is an anabolic agent that acts primarily through modulation of progestin receptors. As an impurity of Norethindrone, this compound retains biological activity relevant to the study of reproductive health disorders. It has utility in research applications focused on endometriosis and other hormonal regulation studies.

Asoprisnil ecamate is an orally active antiprogestin that primarily targets progesterone receptors. It exhibits key biological activity in regulating reproductive processes and is utilized in research applications related to contraception and reproductive health studies. This compound serves as a valuable tool for investigating reproductive endocrine functions and therapeutic approaches in managing fertility-related conditions.

11α-Hydroxytestosterone is a derivative of hydrocortisone that exhibits a relative binding affinity of 9% for the progesterone receptor compared to R5020. This compound demonstrates significant inhibitory effects on the growth and differentiation of human decidual cells in culture. It serves as a valuable reagent for research applications exploring steroid hormone pathways and cellular responses in reproductive biology.

Lilopristone is a potent progesterone antagonist that serves as a valuable tool in reproductive biology research. By blocking progesterone action at the endometrium and reducing its bioavailability, Lilopristone can induce menstruation, inhibit nidation, and facilitate pregnancy termination. Its unique mechanism makes it suitable for investigating antifertility effects and reproductive health studies.

ORG 33628 is a potent and selective progesterone receptor modulator with significant anti-progestational and anti-glucocorticoid properties. This compound exhibits ovulation-inhibitory activity, making it valuable for research in reproductive biology. ORG 33628 has potential applications in the study of conditions related to the breast and endometrium, contributing to insights into hormonal regulation and related therapeutic strategies.

Algestone is a synthetic progestin that primarily acts on progesterone receptors to exert its hormonal effects. It is utilized in research related to hormonal contraception and reproductive health, demonstrating significant activity in modulating reproductive processes. Algestone's properties make it a valuable reagent for studies focusing on contraceptive development and endocrinology.

Gestonorone Capronate is a synthetic progestin that primarily targets the progesterone receptor. It exhibits significant biological activity in regulating hormonal balance, making it useful in the treatment of conditions such as benign prostatic hypertrophy and endometrial cancer. This compound is valuable for research applications related to hormone signaling pathways and therapeutic interventions in progestin-responsive malignancies.